NCT04149743View on ClinicalTrials.gov

HEMOTAG® Assessment for Short-term Outcomes of Heart Failure

NARecruitingINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

January 31, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Heart Failure (HF)
Interventions
DIAGNOSTIC_TEST

Standard of Care with Hemotag

Comparison of outcomes

Trial Locations (2)

33331

RECRUITING

Cleveland Clinic Florida, Weston

76508

RECRUITING

Baylor Scott & White Research Institute, Temple

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Cleveland Clinic Florida

OTHER

lead

Aventusoft, LLC.

INDUSTRY